FDA Breakthroughs: Why Psilocybin and MDMA are Changing Psychiatry in 2026

5.6.2026 copyright@uptown In 2026, the medical community is witnessing a historic paradigm shift as FDA-approved psychedelics like Psilocybin and MDMA transition from controversial substances to frontline clinical treatments for treatment-resistant mental health conditions. The Silent Revolution in Mental Health For decades, psychiatry has relied on the same classes of SSRIs and SNRIs, which often manage … Read more